ON-203

N/A

Report date: 2026/03/19 17:18:46

Base Information

Drug NameON-203

Drug Alias NameON203

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionMacrophage migration inhibitory factor inhibitorsAnti-CD3

TargetsMacrophage migration inhibitory factorT cell surface glycoprotein CD3

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesOncoOne Research & Development GmbH

China Registration ClassN/A

Develop Information

Active CompaniesShanghai Jinsirui Vigorous Biotechnology Co Ltd

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A